RXi Pharmaceuticals Corporation, an RNA-targeted technologies company, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor (CTGF), and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.
In this study, subjects received small skin incisions in their abdomen and were treated with 3 intradermal doses of RXI‑109 over a 2-week period. This dose escalating study consisted of 3 cohorts of 3 healthy volunteers each. Subjects received RXI‑109 on one side of the abdomen, and placebo on the other side.
Subjects were monitored for safety and local and systemic side effects over a total study period of 84 days.
Multiple dermal injections were well tolerated at all doses and treatment with RXI‑109 resulted in dose-dependent silencing of CTGF mRNA in the treated areas.
Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals said that, "We are very pleased with the outcome of this second Phase 1 study. These results show that multiple intradermal injections of RXI‑109 are well tolerated with minimal and mild side effects. He added that, "The work done in the last year has confirmed that our proprietary self-delivering RNAi technology (sd-rxRNA) reduces CTGF mRNA in humans in line with its mechanism of action. Indeed, results from this second study demonstrate that mRNA for CTGF in the incisions is reduced in a dose-dependent manner by RXI‑109 as compared to placebo. Our first Phase 1 study had already shown that a single dose of the drug lowered the actual protein content for CTGF also in a dose-dependent manner. With this exciting outcome, we are ready to embark on Phase 2 development in patients with hypertrophic scars and keloids."
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Double Mastectomy: 'Angelina Effect' Has Been Long-lasting
- Hurricane Polo
- M60-UCD1: Tiny Galaxy, Supermassive Black Hole
- Mysterious 1808 Eruption - The Real Cause Of The Coldest Decade Of The Last 500 Years
- The Wealth Under Afghanistan
- 'Sleep Node' In The Brain Discovered
- Fracking Blamed For Too Many Hotel Rooms
- "According to Wikipedia:So that theory is no longer in town? I had imagined a great voice..."
- "You can find the slides on the indico page of the event: https://indico.cern.ch/event/328735/overview..."
- "Now, now, boys. I attempted to be politically neutral in this column. Even if I didn't totally..."
- "Aether has mass. Aether physically occupies three dimensional space. Aether is physically displaced..."
- "Really, since dark matter is not supposed to interact with normal matter, except gravitationally..."
- Monster galaxies gain weight by eating smaller neighbors
- The 'Angelina Effect' was not only immediate, but also long-lasting
- Experts issue plea for better research and education for advanced breast cancer
- Gun deaths twice as high among African-Americans as white citizens in US
- Cooling of dialysis fluids protects against brain damage